Pulmonary Penetration of Piperacillin and Tazobactam in Critically Ill Patients

Pulmonary infections in critically ill patients are common and are associated with high morbidity and mortality. Piperacillin–tazobactam is a frequently used therapy in critically ill patients with pulmonary infection. Antibiotic concentrations in the lung reflect target‐site antibiotic concentratio...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Felton, T W, McCalman, K, Malagon, I, Isalska, B, Whalley, S, Goodwin, J, Bentley, A M, Hope, W W
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2014
Aiheet:
Clinical Trial
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4169708/
https://ncbi.nlm.nih.gov/pubmed/24926779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2014.131
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia